Rhythm Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-3.207; its P/E ratio is -11.88; Rhythm Pharmaceuticals is scheduled to report earnings on April 30, 2024, and the estimated EPS forecast is $-2.36. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 22.50M	$ 19.22M	-	-	$ 4.28M
Gross Profit	$ 20.09M	$ 16.98M	$ -1.42M	$ -1.03M	$ 3.79M
EBIT	$ -40.65M	$ -43.40M	$ -52.56M	$ -42.82M	$ -38.72M
EBITDA	$ -37.06M	$ -39.83M	$ -49.04M	-	$ -38.27M
Net Income Common Stockholders	$ -44.16M	$ -46.70M	$ -52.18M	$ -42.79M	$ -40.86M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 299.26M	$ 253.60M	$ 294.58M	$ 333.29M	$ 347.80M
Total Assets	$ 354.20M	$ 309.94M	$ 343.68M	$ 382.48M	$ 389.61M
Total Debt	$ 1.44M	$ 1.61M	$ 1.78M	$ 1.94M	$ 2.10M
Net Debt	$ -297.82M	$ -251.99M	$ -292.80M	$ -331.34M	$ -345.69M
Total Liabilities	$ 156.72M	$ 127.66M	$ 125.92M	$ 382.48M	$ 108.42M
Stockholders Equity	$ 197.47M	$ 182.28M	$ 219.76M	$ 264.26M	$ 281.19M
Cash Flow	-
Free Cash Flow	$ -29.52M	$ -41.97M	$ -41.00M	$ -34.00M	$ -47.08M
Operating Cash Flow	$ -29.25M	$ -41.09M	$ -36.43M	$ -34.00M	$ -46.99M
Investing Cash Flow	$ -94.96M	$ 48.19M	$ 18.46M	$ -40.77M	$ -39.70M
Financing Cash Flow	$ 73.04M	$ -965.00K	$ -133.00K	$ 17.36M	$ 158.56M

Currency in USD

Rhythm Pharmaceuticals Earnings and Revenue History

Income Statement >

Rhythm Pharmaceuticals Debt to Assets

Balance Sheet >

Rhythm Pharmaceuticals Cash Flow

Cash Flow >

Rhythm Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing